ES2145254T3 - Formulaciones de aerosoles que contienen flunisolida. - Google Patents

Formulaciones de aerosoles que contienen flunisolida.

Info

Publication number
ES2145254T3
ES2145254T3 ES95901923T ES95901923T ES2145254T3 ES 2145254 T3 ES2145254 T3 ES 2145254T3 ES 95901923 T ES95901923 T ES 95901923T ES 95901923 T ES95901923 T ES 95901923T ES 2145254 T3 ES2145254 T3 ES 2145254T3
Authority
ES
Spain
Prior art keywords
aerosols
formulations containing
flunisolide
containing flunisolide
flunisoluro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95901923T
Other languages
English (en)
Inventor
Tsi-Zong Tzou
Robert K Schultz
Danna L Ross
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
3M Co
Original Assignee
3M Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
Priority to US17050993A priority Critical
Application filed by 3M Co filed Critical 3M Co
Application granted granted Critical
Publication of ES2145254T3 publication Critical patent/ES2145254T3/es
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22620133&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2145254(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Anticipated expiration legal-status Critical
Application status is Expired - Lifetime legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane, progesterone
    • A61K31/573Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane, progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
    • A61K31/58Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin

Abstract

FORMULACIONES DE AEROSOL FARMACEUTICAS QUE COMPRENDEN FLUNISOLURO, ETANOL, Y UN PROPULSOR SELECCIONADO DEL GRUPO QUE CONSTA DE 1.1,1,2-TETRAFLUOROETANO,1,1,1,2,3,3,3HEPTAFLUOROPROPANO, Y UNA MEZCLA DE LOS MISMOS.
ES95901923T 1993-12-20 1994-11-15 Formulaciones de aerosoles que contienen flunisolida. Expired - Lifetime ES2145254T3 (es)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US17050993A true 1993-12-20 1993-12-20

Publications (1)

Publication Number Publication Date
ES2145254T3 true ES2145254T3 (es) 2000-07-01

Family

ID=22620133

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95901923T Expired - Lifetime ES2145254T3 (es) 1993-12-20 1994-11-15 Formulaciones de aerosoles que contienen flunisolida.

Country Status (12)

Country Link
US (2) US5776433A (es)
EP (1) EP0735884B1 (es)
JP (1) JPH09506896A (es)
AU (1) AU680967B2 (es)
CA (1) CA2178473C (es)
DE (2) DE69424181D1 (es)
DK (1) DK0735884T3 (es)
ES (1) ES2145254T3 (es)
NO (1) NO313123B1 (es)
NZ (1) NZ276637A (es)
PT (1) PT735884E (es)
WO (1) WO1995017195A1 (es)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5766573A (en) * 1988-12-06 1998-06-16 Riker Laboratories, Inc. Medicinal aerosol formulations
DK1086688T3 (da) * 1991-12-18 2004-08-16 Minnesota Mining & Mfg Aerosolformuleringer til suspensioner
US7101534B1 (en) 1991-12-18 2006-09-05 3M Innovative Properties Company Suspension aerosol formulations
US7105152B1 (en) 1991-12-18 2006-09-12 3M Innovative Properties Company Suspension aerosol formulations
AU680967B2 (en) * 1993-12-20 1997-08-14 Minnesota Mining And Manufacturing Company Flunisolide aerosol formulations
GB9425160D0 (en) * 1994-12-10 1995-02-08 Glaxo Group Ltd Medicaments
US5874481A (en) * 1995-06-07 1999-02-23 Alliance Pharmaceutical Corp. Fluorochemical solutions for the delivery of lipophilic pharmaceutical agents
GB9616237D0 (en) 1996-08-01 1996-09-11 Norton Healthcare Ltd Aerosol formulations
US6413496B1 (en) 1996-12-04 2002-07-02 Biogland Ireland (R&D) Limited Pharmaceutical compositions and devices for their administration
US6129905A (en) * 1997-04-21 2000-10-10 Aeropharm Technology, Inc. Aerosol formulations containing a sugar as a dispersant
US5891419A (en) * 1997-04-21 1999-04-06 Aeropharm Technology Limited Environmentally safe flunisolide aerosol formulations for oral inhalation
US6120752A (en) * 1997-05-21 2000-09-19 3M Innovative Properties Company Medicinal aerosol products containing formulations of ciclesonide and related steroids
US6264923B1 (en) 1998-05-13 2001-07-24 3M Innovative Properties Company Medicinal aerosol formulation of ciclesonide and related compounds
US20010031244A1 (en) 1997-06-13 2001-10-18 Chiesi Farmaceutici S.P.A. Pharmaceutical aerosol composition
US6197280B1 (en) * 1997-09-09 2001-03-06 Bioglan Laboratories Limited Pharmaceutical compositions and devices for their administration
US20060165606A1 (en) 1997-09-29 2006-07-27 Nektar Therapeutics Pulmonary delivery particles comprising water insoluble or crystalline active agents
DE69806789T2 (de) * 1997-10-13 2003-04-03 Valois Sa Dichtung für ein ventil
TW465235B (en) 1998-09-17 2001-11-21 United Video Properties Inc Electronic program guide with digital storage
US6458338B1 (en) 1998-09-22 2002-10-01 Aeropharm Technology Incorporated Amino acid stabilized medicinal aerosol formulations
US6509005B1 (en) * 1998-10-27 2003-01-21 Virginia Commonwealth University Δ9 Tetrahydrocannabinol (Δ9 THC) solution metered dose inhaler
DZ2947A1 (fr) * 1998-11-25 2004-03-15 Chiesi Farma Spa Inhalateur à compteur de dose sous pression.
US6315985B1 (en) * 1999-06-18 2001-11-13 3M Innovative Properties Company C-17/21 OH 20-ketosteroid solution aerosol products with enhanced chemical stability
IT1313553B1 (it) 1999-07-23 2002-09-09 Chiesi Farma Spa Formulazioni ottimizzate costituite da soluzioni di steroidi dasomministrare per inalazione.
IT1317720B1 (it) * 2000-01-07 2003-07-15 Chiesi Farma Spa Dispositivo per la somministrazione di aerosol dosati pressurizzati inpropellenti idrofluoroalcani.
IT1317846B1 (it) 2000-02-22 2003-07-15 Chiesi Farma Spa Formulazioni contenenti un farmaco anticolinergico per il trattamentodella broncopneumopatia cronica ostruttiva.
US7871598B1 (en) 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
IT1318514B1 (it) * 2000-05-12 2003-08-27 Chiesi Farma Spa Formulazioni contenenti un farmaco glucocorticosteroide per iltrattamento di patologie broncopolmonari.
MXPA02011414A (es) 2000-05-22 2003-06-06 Chiesi Farma Spa Formulaciones farmaceuticas en solucion estable para inhaladores presurizados con medicion de dosis.
US7905230B2 (en) 2001-05-09 2011-03-15 Novartis Ag Metered dose inhaler with lockout
EP1241113A1 (en) 2001-03-12 2002-09-18 CHIESI FARMACEUTICI S.p.A. Inhaler with means for improving chemical stability of medicinal aerosol solution contained therein
US7025058B2 (en) * 2001-04-26 2006-04-11 New England Pharmaceuticals, Inc. Metered dose delivery device for liquid and powder agents
PT1273292E (pt) 2001-07-02 2004-10-29 Chiesi Farma Spa Formulacao optimizada de tobramicina para aerossolizacao
MXPA04005865A (es) 2001-12-19 2004-09-13 Nektar Therapeutics Suministro de aminoglucosidos a los pulmones.
EP1458354A1 (en) * 2001-12-21 2004-09-22 3M Innovative Properties Company Medicinal aerosol formulations comprising ion pair complexes
WO2003074024A1 (en) * 2002-03-01 2003-09-12 Chiesi Farmaceutici S.P.A Formoterol superfine formulation
TW200409746A (en) * 2002-07-26 2004-06-16 Theravance Inc Crystalline β2 adrenergic receptor agonist
WO2005032521A2 (en) * 2003-10-02 2005-04-14 Collegium Pharmaceutical, Inc. Non-flammable topical anesthetic liquid aerosols
US20060188449A1 (en) * 2003-10-03 2006-08-24 Jane Hirsh Topical aerosol foams
AR041873A1 (es) * 2003-10-30 2005-06-01 Pablo Cassara Srl Lab Una formulacion farmaceutica en aerosol adecuada para la inhalacion oral o nasal que contienen glucocorticoides en solucion estable al almacenamiento; un metodo para estabilzar formulaciones y uso de un agente estabilizante
EP1595531A1 (en) 2004-05-13 2005-11-16 CHIESI FARMACEUTICI S.p.A. Stable pharmaceutical solution formulations for pressurized metered dose inhalers
WO2005115336A2 (en) * 2004-05-15 2005-12-08 Collegium Pharmaceutical, Inc. Sprayable formulations for the treatment of acute inflammatory skin conditions
EP1850831B1 (en) 2005-02-25 2015-12-02 CHIESI FARMACEUTICI S.p.A. Pharmaceutical aerosol formulations for pressurized metered dose inhalers comprising a sequestering agent
WO2007030162A2 (en) 2005-05-18 2007-03-15 Nektar Therapeutics Valves, devices, and methods for endobronchial therapy
CA2609579C (en) * 2005-05-27 2014-08-19 Taro Pharmaceuticals North America, Inc. Stable liquid desoximetasone compositions with reduced oxidized impurity
BRPI0616642A2 (pt) 2005-09-29 2011-06-28 Nektar Therapeutics formulações de antibióticos, doses unitárias, kits e métodos
US8227027B2 (en) 2007-12-07 2012-07-24 Presspart Gmbh & Co. Kg Method for applying a polymer coating to an internal surface of a container
US8652443B2 (en) * 2008-02-14 2014-02-18 Precision Dermatology, Inc. Foamable microemulsion compositions for topical administration
EP2350118B1 (en) 2008-09-19 2016-03-30 Nektar Therapeutics Carbohydrate-based drug delivery polymers and conjugates thereof
US20100141969A1 (en) * 2008-12-08 2010-06-10 Brazier David B Method and Apparatus for Making Liquid Flexographic Printing Elements
CA3037273A1 (en) * 2009-10-01 2011-04-07 Fredric Jay Cohen Orally administered corticosteroid compositions
WO2011084316A2 (en) 2009-12-16 2011-07-14 3M Innovative Properties Company Formulations and methods for controlling mdi particle size delivery
GB201221063D0 (en) 2012-11-23 2013-01-09 3M Innovative Properties Co Metered dose dispensing valve
TW201808304A (en) 2016-08-18 2018-03-16 Adare Pharmaceuticals Inc Methods of treating eosinophilic esophagitis

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE555319A (es) * 1956-03-21 1900-01-01
US2885427A (en) * 1956-11-15 1959-05-05 Dow Chemical Co Fluorination of trichloroethylene
US4083954A (en) * 1975-04-04 1978-04-11 Kao Soap Co., Ltd. Aerosol composition
US4933168A (en) * 1975-05-27 1990-06-12 Syntex Pharmaceuticals International Limited Stable, crystalline flunisolide
NL7708731A (nl) * 1976-08-13 1978-02-15 Montedison Spa Werkwijze voor de bereiding van nieuwe drijf- middelsamenstellingen voor aerosolen.
CH634480A5 (de) * 1977-11-25 1983-02-15 Schwarzkopf Gmbh Hans Unter druck stehendes aerosolpraeparat.
US4273710A (en) * 1979-05-21 1981-06-16 Syntex Corporation Process for preparing flunisolide
GB8501015D0 (en) * 1985-01-16 1985-02-20 Riker Laboratories Inc Drug
US4983595A (en) * 1986-05-22 1991-01-08 Syntex (U.S.A.) Inc. Aqueous steroid formulations for nasal administration
US4851211A (en) * 1986-11-25 1989-07-25 Abbott Laboratories LHRH analog formulations
JPH0730311B2 (ja) * 1987-09-21 1995-04-05 ダイキン工業株式会社 冷 媒
US5225183A (en) * 1988-12-06 1993-07-06 Riker Laboratories, Inc. Medicinal aerosol formulations
DE3905726A1 (de) * 1989-02-24 1990-08-30 Hoechst Ag Druckgaspackung und treibmittel fuer aerosole
DE4003272A1 (de) * 1990-02-03 1991-08-08 Boehringer Ingelheim Kg Neue treibgasmischungen und ihre verwendung in arzneimittelzubereitungen
DE4003270A1 (de) * 1990-02-03 1991-08-08 Boehringer Ingelheim Kg Neue treibgase und ihre verwendung in arzneimittelzubereitungen
WO1991014422A1 (en) * 1990-03-23 1991-10-03 Minnesota Mining And Manufacturing Company The use of soluble fluorosurfactants for the preparation of metered-dose aerosol formulations
US5118494A (en) * 1990-03-23 1992-06-02 Minnesota Mining And Manufacturing Company Use of soluble fluorosurfactants for the preparation of metered-dose aerosol formulations
JP2769925B2 (ja) * 1990-10-18 1998-06-25 ミネソタ マイニング アンド マニュファクチャリング カンパニー ベクロメタゾン17,21ジプロピオネートを含んで成るエアロゾル製剤
US5182097A (en) * 1991-02-14 1993-01-26 Virginia Commonwealth University Formulations for delivery of drugs by metered dose inhalers with reduced or no chlorofluorocarbon content
US5190029A (en) * 1991-02-14 1993-03-02 Virginia Commonwealth University Formulation for delivery of drugs by metered dose inhalers with reduced or no chlorofluorocarbon content
EP0504112A3 (en) * 1991-03-14 1993-04-21 Ciba-Geigy Ag Pharmaceutical aerosol formulations
DE69231991D1 (de) * 1991-06-10 2001-09-13 Schering Corp Fluorchlorkohlenwasserstofffreie Aerosolformulierungen
WO1992022288A1 (en) * 1991-06-10 1992-12-23 Schering Corporation Non-chlorofluorocarbon aerosol formulations
DE4123663A1 (de) * 1991-07-17 1993-01-21 Schwabe Willmar Gmbh & Co Aerosol-zubereitung und verwendung eines treibmittels dafuer
US5674471A (en) * 1991-12-12 1997-10-07 Glaxo Group Limited Aerosol formulations containing P134a and salbutamol
DK1086688T3 (da) * 1991-12-18 2004-08-16 Minnesota Mining & Mfg Aerosolformuleringer til suspensioner
US5202110A (en) * 1992-01-22 1993-04-13 Virginia Commonwealth University Formulations for delivery of beclomethasone diproprionate by metered dose inhalers containing no chlorofluorocarbon propellants
JPH08507792A (ja) * 1993-03-17 1996-08-20 ミネソタ マイニング アンド マニュファクチャリング カンパニー ジオール−二酸から誘導される分散助剤を含むエーロゾル配合物
AU680967B2 (en) * 1993-12-20 1997-08-14 Minnesota Mining And Manufacturing Company Flunisolide aerosol formulations
US5695473A (en) * 1994-07-27 1997-12-09 Sims Deltec, Inc. Occlusion detection system for an infusion pump

Also Published As

Publication number Publication date
DE69424181T2 (de) 2000-10-19
EP0735884A1 (en) 1996-10-09
NZ276637A (en) 1997-07-27
WO1995017195A1 (en) 1995-06-29
US5980867A (en) 1999-11-09
CA2178473A1 (en) 1995-06-29
CA2178473C (en) 2004-08-24
DE69424181D1 (de) 2000-05-31
US5776433A (en) 1998-07-07
NO962585D0 (no) 1996-06-18
AU680967B2 (en) 1997-08-14
PT735884E (pt) 2000-09-29
DK0735884T3 (da) 2000-10-09
AU1098695A (en) 1995-07-10
JPH09506896A (ja) 1997-07-08
NO962585L (no) 1996-06-18
EP0735884B1 (en) 2000-04-26
NO313123B1 (no) 2002-08-19
DK735884T3 (es)

Similar Documents

Publication Publication Date Title
DK0679157T3 (da) Nye 3,4-diarylthiophener og analoge deraf til anvendelse som antiinflammatoriske midler
KR920014662A (ko) 에어백용 가스 발생기
DK0732923T3 (da) Farmaceutiske sammensætninger indeholdende HIV-proteaseinhibitorer
UY24555A1 (es) Nuevos compuestos
KR910018387A (ko) 약제학적 화합물
KR900015608A (ko) 수용성을 증가시키는 개량된 조성물
GT199800126A (es) Terapia de combinacion.
DE69105212T2 (de) Aerosolzubereitung, die beclometason 17,21-dipropionat enthält.
MX9102501A (es) Derivados de metano sulfonamida, composiciones farderivados de metanosulfonamida, composiciones farmaceuticas que los contienen y procedimiento para smaceuticas que los contienen y procedimiento para u preparacion. su preparacion.
DK0614660T3 (da) Multipelemulsioner, disses fremstilling og anvendelse til fremstilling af kosmetiske sammensætninger samt kosmetiske sammen
NO307707B1 (no) Spiroazabicykliske forbindelser, farmasøytisk preparat inneholdende slike forbindelser og anvendelse derav
AT26280T (de) 7-acylamino-3-vinylcephalosporansaeurederivate, verfahren zu ihrer herstellung, sie enthaltende pharmazeutische zusammensetzungen, ihre ausgangsverbindungen und deren herstellung.
FI931476A (fi) Indolinderivat med en amidfunktionell grupp, framstaellning av dem och dessa innehaollande farmaceutiska kompositioner
NO322137B1 (no) Anvendelse av cholinesterase-inhibitorer for fremstilling av et farmasoytisk preparat.
NL950007I2 (nl) 1,2,4-Triazinederivaten, werkwijze voor de bereiding van deze verbindingen, en deze verbindingen bevattende farmaceutische preparaten.
AR011069A1 (es) Compuestos amidino, proceso para su preparacion, compuestos intermediarios, formulaciones farmaceuticas que los comprenden, y su uso en la fabricacion de un medicamento como inhibidor de la oxido nitrico sintasa inducible.
IT8921118D0 (it) Composizione per aerosol comprendente nitroglicerina come ingrediente attivo.
MX9200344A (es) Derivados de benzamida, proceso para su preparacion y composicion farmaceutica que los contiene.
AR066982A2 (es) Compuestos heteroaromaticos sustituidos como inhibidoress tirosin quinasa, composiciones farmaceuticas que los contiene y su uso en la preparacion de medicamentos
IT7924466D0 (it) Bocchetta combinata di aggiunta e somministrazione per un contenitore.
ES2104946T3 (es) Ureas ciclicas y similares utiles como inhibidores de la proteasa retrovirica.
TR27328A (tr) Yeni 4-benzoil isoksazol türevleri, bunlari ihtiva eden terkipler ve bunlarin herbisidler olarak kullanimi.
KR920021535A (ko) 다환 아민 화합물 및 그의 거울상 이성질체, 그의 제조방법 및 이를 함유하는 제약학적 조성물
NO901685L (no) Hjelpeanordning for bruk med aerosolbeholder.
FI915458A0 (fi) Heterosykliska, n-substituerade derivat, framstaellning av dessa och farmaceutiska kompositioner innehaollande dessa.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 735884

Country of ref document: ES